Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06624059
What this trial is testing

See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Study completedNCT02038218
What this trial is testing

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

Who this might be right for
Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
DEKK-TEC, Inc. 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT05955391
What this trial is testing

TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Shenzhen TargetRx Co., Ltd. 164
Early research (Phase 1)Study completedNCT05800418
What this trial is testing

Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers

Who this might be right for
Gastric CancerNon-small Cell Lung CancerColo-rectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 88
Large-scale testing (Phase 3)UnknownNCT05042375
What this trial is testing

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 450
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT04880863
What this trial is testing

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
NeoTX Therapeutics Ltd. 38
Testing effectiveness (Phase 2)UnknownNCT04425681
What this trial is testing

Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer

Who this might be right for
Leptomeningeal MetastasisNon-small Cell Lung CancerEGFR Activating Mutation
Second Affiliated Hospital of Nanchang University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05305365
What this trial is testing

Study Assessing QBS72S For Treating Brain Metastases

Who this might be right for
Brain MetastasesBreast CancerLung Cancer+2 more
Stanford University 21
Not applicableLooking for participantsNCT05689619
What this trial is testing

SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)

Who this might be right for
Brain Metastases, AdultNon Small Cell Lung CancerBreast Cancer
A.O.U. Città della Salute e della Scienza 70
Testing effectiveness (Phase 2)Study completedNCT00256711
What this trial is testing

Phase II Iressa Versus Vinorelbine (INVITE)

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 192
Large-scale testing (Phase 3)Study completedNCT01724801
What this trial is testing

Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer

Who this might be right for
Brain MetastasisNon Small Cell Lung Cancer
Guangdong Association of Clinical Trials 176
Testing effectiveness (Phase 2)Looking for participantsNCT05241028
What this trial is testing

Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Hebei Medical University Fourth Hospital 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07043907
What this trial is testing

PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Shenzhen Celconta Life Science Co., Ltd. 115
Testing effectiveness (Phase 2)UnknownNCT05207904
What this trial is testing

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Who this might be right for
Non-Small Cell Squamous Lung CancerBrain Metastases
Sun Yat-sen University 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06475755
What this trial is testing

Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

Who this might be right for
Non-Small Cell Lung CancerAnti Angiogenesis
Tang-Du Hospital 178
Not applicableStudy completedNCT06582849
What this trial is testing

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

Who this might be right for
Bone CancerBrain CancerColorectal Cancer+24 more
Washington University School of Medicine 33
Not applicableStudy completedNCT03170284
What this trial is testing

Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 150
Large-scale testing (Phase 3)Looking for participantsNCT05317858
What this trial is testing

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Who this might be right for
Brain TumorNon Small Cell Lung Cancer
InSightec 30
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Next Page